KENDALL HUSSEY

Cybersecurity research funding; implementation of the FY 2024 National Defense Authorization Act, including Mission Acceleration Center and DCTC program; FY 2025 National Defense Authorization Act.

FY 2023 and 2024 Appropriations, including Regional Biocontainment Laboratories (RBLs), PAHPA reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act; H.R.4420 - Preparedness and Response Reauthorization Act; and H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act.

Higher Education Act Reauthorization; FY 2024 and 2025 appropriations, including Regional Biocontainment Laboratories (RBLs), cybersecurity, concrete, toxic exposure in veterans, additive manufacturing.

Issues related to funding for university research opportunities via FY 2023 and 2024 federal appropriations, FY 2024 defense authorization bill, Regional Biocontainment Laboratories (RBLs), cybersecurity, concreate, additive manufacturing.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); NCI designation.

Issues and funding related to health care workforce challenges; implementation of the Consolidated Appropriations Act, 2023 (H.R. 2617/P.L. 117-328); site-neutral payment policies (H.R.3561 - PATIENT Act of 2023; H.R.5378 - Lower Costs, More Transparency Act); and NCI designation.

CHRISTUS HEALTH SYSTEM

ZELIS HEALTHCARE CORPORATION

FLETCHER GROUP, INC.

UNIVERSITY OF LOUISVILLE

TEXAS ASSOCIATION FOR HOME CARE & HOSPICE

UOFL HEALTH, INC.

BAMBOO HEALTH

ZELIS HEALTHCARE CORPORATION

FLETCHER GROUP, INC.

TEXAS ASSOCIATION FOR HOME CARE & HOSPICE

HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND)

BAMBOO HEALTH